ArticleMolecules (Basel, Switzerland)2022

JND4135, a New Type II TRK Inhibitor, Overcomes TRK xDFG and Other Mutation Resistance In Vitro and In Vivo.

Jie Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.